willis towers watson plc - WTW
WTW
Close Chg Chg %
308.61 5.55 1.80%
Closed Market
314.16
+5.55 (1.80%)
Volume: 615.82K
Last Updated:
Nov 21, 2024, 4:00 PM EDT
Company Overview: willis towers watson plc - WTW
WTW Key Data
| Open $309.80 | Day Range 307.14 - 315.67 |
| 52 Week Range 234.03 - 320.78 | Market Cap $31.08B |
| Shares Outstanding 100.73M | Public Float 100.41M |
| Beta 0.74 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$7.17 |
| Yield 112.76% | Dividend $0.88 |
| EX-DIVIDEND DATE Sep 30, 2024 | SHORT INTEREST N/A |
| AVERAGE VOLUME 687.45K |
WTW Performance
| 1 Week | 0.48% | ||
| 1 Month | 8.16% | ||
| 3 Months | 11.62% | ||
| 1 Year | 28.61% | ||
| 5 Years | 65.56% |
WTW Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
23
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 337.167 | |
| Number of Ratings | 23 | Current Quarters Estimate | 7.951 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 16.683 | |
| Last Quarter’s Earnings | 2.93 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 14.49 | Next Fiscal Year Estimate | 18.08 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 19 | 18 | 20 | 20 |
| Mean Estimate | 7.95 | 3.61 | 16.68 | 18.08 |
| High Estimates | 8.33 | 3.94 | 17.10 | 19.53 |
| Low Estimate | 6.89 | 3.34 | 15.62 | 17.20 |
| Coefficient of Variance | 4.34 | 4.13 | 1.97 | 3.92 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 8 | 8 | 9 |
| OVERWEIGHT | 4 | 4 | 4 |
| HOLD | 9 | 9 | 9 |
| UNDERWEIGHT | 1 | 1 | 0 |
| SELL | 1 | 1 | 1 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Willis Towers Watson Plc - WTW
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Willis Towers Watson Plc - WTW
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Oct 4, 2024 | Alexis Faber Chief Operating Officer | 6,593 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Oct 4, 2024 | Joseph S. Kurpis PAO and Controller | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Oct 4, 2024 | Pamela Jane Thomson-Hall Head of International | 3,735 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $294.53 per share | 1,100,069.55 |
| Oct 4, 2024 | Alexis Faber Chief Operating Officer | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Oct 4, 2024 | Lucy Clarke President of Risk & Broking | 13,306 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 4, 2024 | Lucy Clarke President of Risk & Broking | 18,462 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 4, 2024 | Alexis Faber Chief Operating Officer | 5,573 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $294.53 per share | 1,641,415.69 |
| Oct 4, 2024 | Joseph S. Kurpis PAO and Controller | 871 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $294.53 per share | 256,535.63 |
| Oct 4, 2024 | Pamela Jane Thomson-Hall Head of International | 4,583 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Oct 4, 2024 | Joseph S. Kurpis PAO and Controller | 982 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Oct 4, 2024 | Lucy Clarke President of Risk & Broking | 3,326 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 4, 2024 | Pamela Jane Thomson-Hall Head of International | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jul 18, 2024 | Julie Jarecke Gebauer Head of Health, Wealth &Career | 73,922 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 18, 2024 | Carl Aaron Hess Chief Executive Officer; Director | 92 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 18, 2024 | Matthew S. Furman General Counsel | 34,819 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 18, 2024 | Julie Jarecke Gebauer Head of Health, Wealth &Career | 23,053 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 18, 2024 | Julie Jarecke Gebauer Head of Health, Wealth &Career | 5,151 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 18, 2024 | Carl Aaron Hess Chief Executive Officer; Director | 79,721 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 18, 2024 | Andrew Krasner Chief Financial Officer | 589 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 18, 2024 | Andrew Krasner Chief Financial Officer | 21 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |